Literature DB >> 28941085

Antidepressants and suicide risk in depression.

Philppe Courtet1,2, Jorge Lopez-Castroman2,3.   

Abstract

Entities:  

Year:  2017        PMID： 28941085      PMCID： PMC5608853          DOI： 10.1002/wps.20460

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

1.  Antidepressants and suicide.

Authors:  Gregory Simon
Journal:  BMJ       Date:  2008-02-14

2.  The Controversial Issue of Euthanasia in Patients With Psychiatric Illness.

Authors:  Emilie Olié; Philippe Courtet
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

Review 3.  Antidepressants and Suicidality.

Authors:  David A Brent
Journal:  Psychiatr Clin North Am       Date:  2016-06-24

4.  Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial.

Authors:  Yoram Yovell; Gali Bar; Moti Mashiah; Yehuda Baruch; Irina Briskman; Jack Asherov; Amit Lotan; Amihai Rigbi; Jaak Panksepp
Journal:  Am J Psychiatry       Date:  2015-12-18       Impact factor: 18.112

5.  SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM.

Authors:  Jorge Lopez-Castroman; Isabelle Jaussent; Philip Gorwood; Philippe Courtet
Journal:  Depress Anxiety       Date:  2016-02-16       Impact factor: 6.505

Review 6.  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Authors:  Marc Stone; Thomas Laughren; M Lisa Jones; Mark Levenson; P Chris Holland; Alice Hughes; Tarek A Hammad; Robert Temple; George Rochester
Journal:  BMJ       Date:  2009-08-11

7.  Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication.

Authors:  M K Nock; I Hwang; N A Sampson; R C Kessler
Journal:  Mol Psychiatry       Date:  2009-03-31       Impact factor: 15.992
  7 in total
  12 in total

Review 1.  Achieving health equity in US suicides: a narrative review and commentary.

Authors:  Seth W Perry; Holly C Wilcox; Jacob C Rainey; Stephen Allison; Tarun Bastiampillai; Ma-Li Wong; Julio Licinio; Steven S Sharfstein
Journal:  BMC Public Health       Date:  2022-07-15       Impact factor: 4.135

2.  A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.

Authors:  Eva M Peñas-Lledó; Sebastien Guillaume; Fernando de Andrés; Ana Cortés-Martínez; Jonathan Dubois; Jean Pierre Kahn; Marion Leboyer; Emilie Olié; Adrián LLerena; Philippe Courtet
Journal:  Transl Psychiatry       Date:  2022-10-18       Impact factor: 7.989

Review 3.  Circular RNA in Schizophrenia and Depression.

Authors:  Zexuan Li; Sha Liu; Xinrong Li; Wentao Zhao; Jing Li; Yong Xu
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

4.  Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study.

Authors:  Adem T Can; Daniel F Hermens; Megan Dutton; Cyrana C Gallay; Emma Jensen; Monique Jones; Jennifer Scherman; Denise A Beaudequin; Cian Yang; Paul E Schwenn; Jim Lagopoulos
Journal:  Transl Psychiatry       Date:  2021-02-04       Impact factor: 7.989

5.  The path not taken: Distinguishing individuals who die by suicide from those who die by natural causes despite a shared history of suicide attempt.

Authors:  Eleanor E Beale; James Overholser; Stephanie Gomez; Sidney Brannam; Craig A Stockmeier
Journal:  J Clin Psychol       Date:  2021-07-31

6.  The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients.

Authors:  Andreea Romaniuc; Rodica Bălaşa; Nicoleta Ştirbu; Smaranda Maier; Sebastian Andone; Zoltan Bajko; Laura Bărcuţean; Septimiu Voidăzan; Anca Moţăţăianu
Journal:  Behav Neurol       Date:  2020-01-21       Impact factor: 3.342

7.  Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Authors:  Susanne Stübner; Renate Grohmann; Waldemar Greil; Xueqiong Zhang; Bruno Müller-Oerlinghausen; Stefan Bleich; Eckart Rüther; Hans-Jürgen Möller; Rolf Engel; Peter Falkai; Sermin Toto; Siegfried Kasper; Alexandra Neyazi
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

8.  DSM-5 Criteria and Depression Severity: Implications for Clinical Practice.

Authors:  Julio C Tolentino; Sergio L Schmidt
Journal:  Front Psychiatry       Date:  2018-10-02       Impact factor: 4.157

9.  Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.

Authors:  Domenico De Berardis; Michele Fornaro; Annalisa Anastasia; Federica Vellante; Luigi Olivieri; Gabriella Rapini; Nicola Serroni; Laura Orsolini; Alessandro Valchera; Alessandro Carano; Carmine Tomasetti; Antonio Ventriglio; Massimiliano Bustini; Maurizio Pompili; Gianluca Serafini; Giampaolo Perna; Felice Iasevoli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Braz J Psychiatry       Date:  2020-03-09       Impact factor: 2.697

10.  Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial.

Authors:  Lisa Tully; John Humiston; Alan Cash
Journal:  Obstet Gynecol Sci       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.